Scientific Committee
NATA's Scientific Committee is comprised of up to 30 members. Additionally, members of the Board of Directors are ex-officio members of the Scientific Committee. Members are chosen according to their expertise in at least one of NATA’s areas of interest. They are appointed for a three-year term, after which time they can be re-elected. Composition of the Committee should reflect the diversity of specialties involved in transfusion medicine.
NATA Scientific Committee (2012–2014)
|
Jean-François Hardy (Chair) Montreal, QC, Canada Michael Auerbach Baltimore, MD, USA Elvira Bisbe Barcelona, Spain Christian Breymann Zurich, Switzerland Jeffrey L. Carson New Brunswick, NJ, USA Dean A. Fergusson Ottawa, ON, Canada Thomas Frietsch Marburg, Germany José A. García-Erce Zaragoza, Spain Anne Godier Paris, France Hans Gombotz Linz, Austria Lawrence Tim Goodnough Stanford, CA, USA Oliver Habler Frankfurt, Germany Ernil Hansen Regensburg, Germany Beverley J. Hunt London, UK Giovanni Inghilleri Milan, Italy Marcos Intaglietta La Jolla, CA, USA Pär I. Johansson Copenhagen, Denmark |
Sybille A. Kozek-Langenecker Vienna, Austria Jacques Lacroix Montreal, QC, Canada Santiago Ramón Leal-Noval Seville, Spain Marcel Levi Amsterdam, the Netherlands Jens Meier Tübingen, Germany Rainer Moog Munich, Germany Hiroshi Morimatsu Okayama, Japan Manuel Muñoz Málaga, Spain Helen V. New London, UK Yves Ozier Brest, France Michael Piagnerelli Brussels, Belgium Charles-Marc Samama Paris, France Dafydd Thomas Swansea, Wales, UK Amy G. Tsai La Jolla, CA, USA Constantine E. Vagianos Piraeus, Greece Philippe Van der Linden Brussels, Belgium |